Physician profile
Eric S Seiger
NPI 1912904772
$5,524.82
in general payments reported to CMS, 2019-2025
22 companies · $2,040 in 2025
The $2,040 reported for 2025 was more than what 76% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $489 · 2021: $623 · 2022: $417 · 2023: $610 · 2024: $897 · 2025: $2,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,174 · Travel and Lodging: $208 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,173.79 |
| Travel and Lodging | $207.92 |
| Education | $164.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $2,424.67 | 2024-2025 | Daxxify |
| Abbvie INC. | $684.01 | 2019-2024 | Rinvoq, Skyrizi |
| Allergan, INC. | $549.57 | 2019-2022 | |
| Janssen Biotech, INC. | $468.63 | 2020-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $340.83 | 2019-2024 | |
| Microaire Surgical Instruments LLC | $207.92 | 2025 | |
| Boston Scientific Corporation | $142.91 | 2020-2023 | Varithena Administration Pack |
| Regeneron Healthcare Solutions, INC. | $108.92 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $106.32 | 2024-2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $100.05 | 2020-2022 | |
| Genzyme Corporation | $75.44 | 2019-2023 | |
| Lilly USA, LLC | $71.63 | 2021-2023 | Olumiant, Taltz |
| Ucb, INC. | $44.87 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.82 | 2023 | Spevigo |
| Dermavant Sciences, INC. | $41.23 | 2023-2024 | Vtama |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $23.01 | 2019 | |
| Verrica Pharmaceuticals INC. | $19.80 | 2023 | Ycanth |
| Arcutis Biotherapeutics, INC. | $17.15 | 2024 | Zoryve |
| Mayne Pharma Commercial LLC | $14.75 | 2019 | |
| Arteriocyte Medical Systems, INC. | $14.39 | 2019 | |
| Merz North America, INC. | $12.45 | 2019 | |
| Biofrontera INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Seiger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.